HTx workshop at the 10th Adriatic and 7th Croatian Congress of Pharmacoeconomics and Outcomes Research
On the 2nd of June 2022, the HTx consortium has organised a successful pre-conference workshop at the Adriatic Congress …
17 June, 2022On December the 4th 2020, more than 70 stakeholders – regulators, payers, patient representatives – from Eastern Europe took part in a webinar organised by the Medical University of Sofia with the help of Syreon Research Institute and EURODIS. The webinar was focusing on the implementation barriers of
All HTx consortium partners met for the second time in Bern, Switzerland at the HTx General Assembly 2020 between February 6-7. The program started with an overview of HTx’s first year from the project coordinator, Wim Goettsch (University of Utrecht) followed by opening remarks from Georgia Salanti
The conceptual framework of the HTx case study on Diabetes was presented at the poster section of the International Conference of Advanced Technologies & Treatments for Diabetes in Madrid, held between 19-22 February 2020. The HTx consortium was represented by Gema García Sáez and Maria Elena Hernando from the Universidad Politécnica
The framework and potentials of HTx were discussed at the ISPOR Europe 2019 conference within the ISPOR IDEAS LAB in Copenhagen, November 2019. HTx was presented by Wim Goettsch, Associate Professor for HTA at Utrecht University (Utrecht, Netherlands). You can find the abstract of the
The concept of the HTx diabetes case study was presented at the Annual Conference of the Biomedical Engineering Spanish Society held between 27-29 November 2019, in Santander, Spain. The HTx Consortium was represented by the Universidad Politécnica de Madrid, (Madrid, Spain). Scroll down for the poster abstract
The concept and aims of the HTx project, highlighting the potentials for collaboration was disseminated extensively for various stakeholders in Bulgaria during 2019. These activities – lead by Guenka Petrova from the Medical University of Sofia – included: June 7, 2019 – HTx concept presented
The first Expert Forum of HTx was held in Barcelona, on the 25th of November, 2019. The meeting proved to be an excellent platform for sharing with and learning from other H2020 and IMI projects such as IMI Prefer, IMI EHDEN, IMI-GetReal H2020 HTA Impact,
On the 29th of November 2019, two patient representatives, from Eurordis – Rare Diseases Europe and from EMSP – European Multiple Sclerosis Platform, visited the Institute of Social and Preventive Medicine (ISPM) at the University of Bern, led by Prof Georgia Salanti, responsible for a
The early results of HTx were presented at the Graduate School for Health Sciences Symposium (November 19 – 20, 2019) in Thun, Switzerland by two PhD students of University of Bern. Poster title: ‘A two-stage prediction model for heterogeneous effects for many treatment options’ Poster presenter: Konstantina
The HTx project was presented in a keynote lecture at the Pharmaceutical Pricing and Reimbursement (PPRI) Conference in Vienna (Austria), on the 24th of October 2019. Title: The need for better HTA methodology for more complex and personalised medicine Presenter: Wim Goettsch, Utrecht University, The
On the 13th of September 2019, three patient representatives from Eurordis – Rare Diseases Europe visited the Data Analysis and Inference Group, conducted by Juha Röning, at the University of Oulu (Finland), a is Lead Partner in the HTx Consortium. The visit aimed at sharing academics’
On the 2nd of June 2022, the HTx consortium has organised a successful pre-conference workshop at the Adriatic Congress …
17 June, 2022Between the 20th – 21st of April 2022, the fourth HTx General Assembly took place in Budapest, Hungary. The two-day hybr…
17 June, 2022The Webinar on diabetes entitled “Developing prediction models to support healthcare decision making for diabetes: ratio…
11 March, 2022On the 29th of November, a digital workshop was hosted from 13:00-17:00 CET. The aim of this workshop was firstly to exc…
20 December, 2021On the 25th of November 2021, HTx organised the third Expert Forum, a yearly meeting to connect with and collect input f…
10 December, 2021Between 4 – 5 November 2021 HTx members organised a workshop in Utrecht, sharing the new methods developed in predictive…
10 November, 2021HTx consortium members at National Institute for Health and Care Excellence (NICE), UK, NHS England and NHS Improvement,…
04 October, 2021HTx holds its first ‘Policy Sandbox’ event to develop HTA methods guidance for COVID-19 diagnostics and treatments On Au…
12 August, 2021On the 11th of June, 30 experts, mainly from HTx, its partners, and representatives from Payer organisations of CEE and …
17 June, 2021The third HTx forum took place online on the 7th June 2021 with the attendance of forum members and representatives of H…
07 June, 2021On May 24th, 2021, representatives from 11 global HTA agencies took part in a roundtable workshop organised by HTx partn…
31 May, 2021The 3rd HTx General Assembly took place online between 24th – 25th March, with the attendance of all HTx consortium part…
26 March, 2021On December the 4th 2020, more than 70 stakeholders – regulators, payers, patient representatives – from Eastern E…
22 January, 2021All HTx consortium partners met for the second time in Bern, Switzerland at the HTx General Assembly 2020 between Februa…
01 April, 2020The conceptual framework of the HTx case study on Diabetes was presented at the poster section of the International Conf…
16 March, 2020Hello! This is the Gutenberg block you can edit directly from the WPBakery Page Builder.
OUR NEXT EVENT
Barcelona 25-26 NOV, 2019